Special Drug Use Surveillance for Entresto Tablets

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

NCT00907998 ·Status: COMPLETED ·Phase: PHASE1

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

NCT00159614 ·Status: COMPLETED ·Phase: PHASE2

A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs

NCT06708611 ·Status: WITHDRAWN ·Phase: PHASE4

A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy

NCT05879523 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function

NCT03318809 ·Status: COMPLETED ·Phase: PHASE1

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

NCT05096143 ·Status: COMPLETED

Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction

NCT03506412 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

NCT04083339 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients

NCT00043771 ·Status: COMPLETED ·Phase: PHASE2

Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder

NCT06206512 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)

NCT00568594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

NCT03772041 ·Status: COMPLETED ·Phase: PHASE3

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

NCT02768298 ·Status: COMPLETED ·Phase: PHASE4

Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity

NCT06331806 ·Status: RECRUITING ·Phase: NA

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

NCT02468232 ·Status: COMPLETED ·Phase: PHASE3

European Study of Dronedarone in Atrial Fibrillation

NCT00697086 ·Status: COMPLETED ·Phase: PHASE3

Phase Ib/IIa Trial With AC01 in Patients With HFrEF

NCT05642507 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure

NCT01120210 ·Status: COMPLETED ·Phase: PHASE2

A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure

NCT07218627 ·Status: RECRUITING ·Phase: PHASE1

Ertugliflozin in Chronic Heart Failure

NCT04438213 ·Status: RECRUITING ·Phase: PHASE2

Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis

NCT02754518 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

NCT01115855 ·Status: COMPLETED ·Phase: PHASE3

European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure

NCT00696631 ·Status: TERMINATED ·Phase: PHASE3

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

NCT01922089 ·Status: COMPLETED ·Phase: PHASE2

Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

NCT00347087 ·Status: COMPLETED ·Phase: PHASE4